ISO/TC 212
| Registration number (WIID) | Project No. | Title | Status |
|---|---|---|---|
| 67022 | ISO 17822:2020 | In vitro diagnostic test systems — Nucleic acid amplification-based examination procedures for detection and identification of microbial pathogens — Laboratory quality practice guide | Standarts spēkā |
| 76677 | ISO 15189:2022 | Medical laboratories — Requirements for quality and competence | Standarts spēkā |
| 69445 | ISO/TS 20914:2019 | Medical laboratories — Practical guidance for the estimation of measurement uncertainty | Standarts spēkā |
| 67217 | ISO 20186-1:2019 | Molecular in vitro diagnostic examinations — Specifications for pre-examination processes for venous whole blood — Part 1: Isolated cellular RNA | Standarts spēkā |
| 69802 | ISO 20166-2:2018 | Molecular in vitro diagnostic examinations — Specifications for pre-examinations processes for formalin-fixed and paraffin-embedded (FFPE) tissue — Part 2: Isolated proteins | Standarts spēkā |
| 79379 | ISO 16256:2021 | Clinical laboratory testing and in vitro diagnostic test systems — Broth micro-dilution reference method for testing the in vitro activity of antimicrobial agents against yeast fungi involved in infectious diseases | Standarts spēkā |
| 81712 | ISO/TS 5798:2022 | In vitro diagnostic test systems — Requirements and recommendations for detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by nucleic acid amplification methods | Standarts spēkā |
| 54976 | ISO 15197:2013 | In vitro diagnostic test systems — Requirements for blood-glucose monitoring systems for self-testing in managing diabetes mellitus | Standarts spēkā |
| 71293 | ISO 35001:2019 | Biorisk management for laboratories and other related organisations | Standarts spēkā |
| 72141 | ISO/TS 16782:2016 | Clinical laboratory testing — Criteria for acceptable lots of dehydrated Mueller-Hinton agar and broth for antimicrobial susceptibility testing | Standarts spēkā |
Displaying 111-120 of 146 results.